250 related articles for article (PubMed ID: 21474828)
1. Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes.
Babaev VR; Runner RP; Fan D; Ding L; Zhang Y; Tao H; Erbay E; Görgün CZ; Fazio S; Hotamisligil GS; Linton MF
Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1283-90. PubMed ID: 21474828
[TBL] [Abstract][Full Text] [Related]
2. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
[TBL] [Abstract][Full Text] [Related]
3. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
4. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
5. Macrophages, inflammation, and atherosclerosis.
Linton MF; Fazio S
Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S35-40. PubMed ID: 14704742
[TBL] [Abstract][Full Text] [Related]
6. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities.
Makowski L; Brittingham KC; Reynolds JM; Suttles J; Hotamisligil GS
J Biol Chem; 2005 Apr; 280(13):12888-95. PubMed ID: 15684432
[TBL] [Abstract][Full Text] [Related]
7. Disruption of endothelial peroxisome proliferator-activated receptor γ accelerates diet-induced atherogenesis in LDL receptor-null mice.
Qu A; Shah YM; Manna SK; Gonzalez FJ
Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):65-73. PubMed ID: 22015658
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
9. Regulation of metabolic responses by adipocyte/macrophage Fatty Acid-binding proteins in leptin-deficient mice.
Cao H; Maeda K; Gorgun CZ; Kim HJ; Park SY; Shulman GI; Kim JK; Hotamisligil GS
Diabetes; 2006 Jul; 55(7):1915-22. PubMed ID: 16804058
[TBL] [Abstract][Full Text] [Related]
10. Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice.
Babaev VR; Hebron KE; Wiese CB; Toth CL; Ding L; Zhang Y; May JM; Fazio S; Vickers KC; Linton MF
J Lipid Res; 2014 Nov; 55(11):2296-308. PubMed ID: 25240046
[TBL] [Abstract][Full Text] [Related]
11. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.
Boord JB; Maeda K; Makowski L; Babaev VR; Fazio S; Linton MF; Hotamisligil GS
Circulation; 2004 Sep; 110(11):1492-8. PubMed ID: 15353487
[TBL] [Abstract][Full Text] [Related]
12. RP105 deficiency attenuates early atherosclerosis via decreased monocyte influx in a CCR2 dependent manner.
Wezel A; van der Velden D; Maassen JM; Lagraauw HM; de Vries MR; Karper JC; Kuiper J; Bot I; Quax PH
Atherosclerosis; 2015 Jan; 238(1):132-9. PubMed ID: 25484103
[TBL] [Abstract][Full Text] [Related]
13. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
14. Loss of 2 Akt (Protein Kinase B) Isoforms in Hematopoietic Cells Diminished Monocyte and Macrophage Survival and Reduces Atherosclerosis in Ldl Receptor-Null Mice.
Babaev VR; Ding L; Zhang Y; May JM; Ramsey SA; Vickers KC; Linton MF
Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):156-169. PubMed ID: 30567482
[TBL] [Abstract][Full Text] [Related]
15. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
Boss M; Kemmerer M; Brüne B; Namgaladze D
Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
[TBL] [Abstract][Full Text] [Related]
16. PPARγ (Peroxisome Proliferator-Activated Receptor γ) Deacetylation Suppresses Aging-Associated Atherosclerosis and Hypercholesterolemia.
Zahr T; Liu L; Chan M; Zhou Q; Cai B; He Y; Aaron N; Accili D; Sun L; Qiang L
Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):30-44. PubMed ID: 36453279
[TBL] [Abstract][Full Text] [Related]
17. Role of the fatty acid binding protein mal1 in obesity and insulin resistance.
Maeda K; Uysal KT; Makowski L; Görgün CZ; Atsumi G; Parker RA; Brüning J; Hertzel AV; Bernlohr DA; Hotamisligil GS
Diabetes; 2003 Feb; 52(2):300-7. PubMed ID: 12540600
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E receptor-2 deficiency enhances macrophage susceptibility to lipid accumulation and cell death to augment atherosclerotic plaque progression and necrosis.
Waltmann MD; Basford JE; Konaniah ES; Weintraub NL; Hui DY
Biochim Biophys Acta; 2014 Sep; 1842(9):1395-405. PubMed ID: 24840660
[TBL] [Abstract][Full Text] [Related]
19. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.
Yu M; Jiang M; Chen Y; Zhang S; Zhang W; Yang X; Li X; Li Y; Duan S; Han J; Duan Y
J Biol Chem; 2016 Aug; 291(33):16977-89. PubMed ID: 27358406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
